Kim Hing Chan - Net Worth and Insider Trading

Kim Hing Chan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kim Hing Chan owns 2 companies in total, including EUDA Health Holdings Ltd (EUDA) , and 8i Acquisition 2 Corp (LAX) .

Click here to see the complete history of Kim Hing Chan’s form 4 insider trades.

Insider Ownership Summary of Kim Hing Chan

Ticker Comapny Transaction Date Type of Owner
EUDA EUDA Health Holdings Ltd 2022-11-17 director
LAX 8i Acquisition 2 Corp 2022-11-17 director

Kim Hing Chan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Kim Hing Chan Ownership Network

Ownership Network List of Kim Hing Chan

No Data

Ownership Network Relation of Kim Hing Chan


Kim Hing Chan Owned Company Details

What does EUDA Health Holdings Ltd do?

Who are the key executives at EUDA Health Holdings Ltd?

Kim Hing Chan is the director of EUDA Health Holdings Ltd. Other key executives at EUDA Health Holdings Ltd include director & CHIEF EXECUTIVE OFFICER Chen Wei Wen Kelvin , CHIEF TECHNOLOGY OFFICER Daniel Tan , and CHIEF FINANCIAL OFFICER Steven John Sobak .

EUDA Health Holdings Ltd (EUDA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of EUDA Health Holdings Ltd (EUDA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of EUDA Health Holdings Ltd (EUDA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

EUDA Health Holdings Ltd (EUDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

EUDA Health Holdings Ltd Insider Transactions

No Available Data

Kim Hing Chan Mailing Address

Above is the net worth, insider trading, and ownership report for Kim Hing Chan. You might contact Kim Hing Chan via mailing address: C/o 1 Pemimpin Drive #12-07, One Pemimpin Singapore, Singapore U0 576151.

Discussions on Kim Hing Chan

No discussions yet.